Vaccines for developing countries: the costs and benefits of waiving patents

Vaitilingam, Romesh (2021) Vaccines for developing countries: the costs and benefits of waiving patents. LSE Business Review (20 May 2021). Blog Entry.

Text (businessreview-2021-05-20-vaccines-for-developing-countries-the-costs) - Published Version Download (63kB)

• https://blogs.lse.ac.uk/businessreview/2...

Abstract

There is much debate about whether the patents on COVID-19 vaccines should be waived to allow low-income countries to produce doses for themselves. The Initiative on Global Markets Forum’s survey asked European and US experts to express their views on this issue and the broader challenges of vaccinating the world. Romesh Vaitilingam sums up the results of the survey.

Item Type:	Online resource (Blog Entry)
Official URL:	https://blogs.lse.ac.uk/businessreview/
Additional Information:	© 2021 The Author
Divisions:	LSE
Subjects:	H Social Sciences > HD Industries. Land use. Labor H Social Sciences > HD Industries. Land use. Labor > HD28 Management. Industrial Management R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine H Social Sciences > HV Social pathology. Social and public welfare. Criminology
Date Deposited:	23 Jul 2021 11:09
Last Modified:	14 Sep 2024 03:06
URI:	http://eprints.lse.ac.uk/id/eprint/111263

Actions (login required)

View Item